What’s new in neonatal jaundice?

This article reviews current issues in the risk management of neonatal jaundice. These include discussion of challenging aspects of the recent National Institute for Clinical Excellence (NICE) guideline, an account of an evidence update for this guideline and consideration of possible future developments, including screening for bilirubin encephalopathy, audit of current practice and surveillance for severe hyperbilirubinaemia.